Literature DB >> 6610533

Models of adoptive T-cell-mediated regression of established tumors.

R J North.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6610533     DOI： 10.1007/978-1-4757-1445-6_12

Source DB:  PubMed          Journal:  Contemp Top Immunobiol        ISSN： 0093-4054


× No keyword cloud information.
  6 in total

Review 1.  Post-transplant adoptive T-cell immunotherapy.

Authors:  Nicole A Aqui; Carl H June
Journal:  Best Pract Res Clin Haematol       Date:  2008-09       Impact factor: 3.020

2.  Enhanced primary resistance to Treponema pallidum infection and increased susceptibility to toxoplasmosis in T-cell-depleted guinea pigs.

Authors:  C S Pavia
Journal:  Infect Immun       Date:  1986-08       Impact factor: 3.441

3.  Comparative methodologies of regulatory T cell depletion in a murine melanoma model.

Authors:  Norimasa Matsushita; Shari A Pilon-Thomas; Lisa M Martin; Adam I Riker
Journal:  J Immunol Methods       Date:  2008-02-13       Impact factor: 2.303

4.  Interleukin 1-induced, T cell-mediated regression of immunogenic murine tumors. Requirement for an adequate level of already acquired host concomitant immunity.

Authors:  R J North; R H Neubauer; J J Huang; R C Newton; S E Loveless
Journal:  J Exp Med       Date:  1988-12-01       Impact factor: 14.307

5.  Cyclophosphamide (Cy)-facilitated adoptive immunotherapy of a Cy-resistant tumour. Evidence that Cy permits the expression of adoptive T-cell mediated immunity by removing suppressor T cells rather than by reducing tumour burden.

Authors:  M Awwad; R J North
Journal:  Immunology       Date:  1988-09       Impact factor: 7.397

6.  Immunologically mediated regression of a murine lymphoma after treatment with anti-L3T4 antibody. A consequence of removing L3T4+ suppressor T cells from a host generating predominantly Lyt-2+ T cell-mediated immunity.

Authors:  M Awwad; R J North
Journal:  J Exp Med       Date:  1988-12-01       Impact factor: 14.307
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.